{"title":"家族性阿尔茨海默病PSEN1基因R278I突变","authors":"Jong Hun Kim, Seong Hye Choi, Jun Hong Lee","doi":"10.12779/dnd.2020.19.1.33","DOIUrl":null,"url":null,"abstract":"Familial Alzheimer disease (AD) is caused by mutations in the PSEN1, PSEN2 and APP genes. In rare cases, mutations in ABCA7 and SORL1 also show familial AD, depending on their positions in the proteins.1,2 About 5% of early onset AD (EOAD) are caused by mutations of these 5 genes.3 The clues about having causal gene mutations in EOAD are the age of onset and number of EOAD patients in their families. If EOAD patients have one or more relatives with EOAD, 77% of their families have the causal gene mutations.4 In sporadic cases, the causal gene can be identified at a very low rate of 17.9% for patients of age at onset under 50 and 1.2% for those over 50.4 Familial EOAD cases have been reported due to a loss of function mutations that seriously alter the function of the ABCA7 gene.2 The mutations in genes other than ABCA7 make it difficult to determine pathogenicity. In this letter, we report a case of the R278I mutation in PSEN1, which has not been reported in Korean familial EOAD patients.","PeriodicalId":72779,"journal":{"name":"Dementia and neurocognitive disorders","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/b3/dnd-19-33.PMC7105715.pdf","citationCount":"0","resultStr":"{\"title\":\"The R278I Mutation of <i>PSEN1</i> in the Familial Alzheimer Disease.\",\"authors\":\"Jong Hun Kim, Seong Hye Choi, Jun Hong Lee\",\"doi\":\"10.12779/dnd.2020.19.1.33\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Familial Alzheimer disease (AD) is caused by mutations in the PSEN1, PSEN2 and APP genes. In rare cases, mutations in ABCA7 and SORL1 also show familial AD, depending on their positions in the proteins.1,2 About 5% of early onset AD (EOAD) are caused by mutations of these 5 genes.3 The clues about having causal gene mutations in EOAD are the age of onset and number of EOAD patients in their families. If EOAD patients have one or more relatives with EOAD, 77% of their families have the causal gene mutations.4 In sporadic cases, the causal gene can be identified at a very low rate of 17.9% for patients of age at onset under 50 and 1.2% for those over 50.4 Familial EOAD cases have been reported due to a loss of function mutations that seriously alter the function of the ABCA7 gene.2 The mutations in genes other than ABCA7 make it difficult to determine pathogenicity. In this letter, we report a case of the R278I mutation in PSEN1, which has not been reported in Korean familial EOAD patients.\",\"PeriodicalId\":72779,\"journal\":{\"name\":\"Dementia and neurocognitive disorders\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/b3/dnd-19-33.PMC7105715.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dementia and neurocognitive disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12779/dnd.2020.19.1.33\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/2/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and neurocognitive disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12779/dnd.2020.19.1.33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/2/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
The R278I Mutation of PSEN1 in the Familial Alzheimer Disease.
Familial Alzheimer disease (AD) is caused by mutations in the PSEN1, PSEN2 and APP genes. In rare cases, mutations in ABCA7 and SORL1 also show familial AD, depending on their positions in the proteins.1,2 About 5% of early onset AD (EOAD) are caused by mutations of these 5 genes.3 The clues about having causal gene mutations in EOAD are the age of onset and number of EOAD patients in their families. If EOAD patients have one or more relatives with EOAD, 77% of their families have the causal gene mutations.4 In sporadic cases, the causal gene can be identified at a very low rate of 17.9% for patients of age at onset under 50 and 1.2% for those over 50.4 Familial EOAD cases have been reported due to a loss of function mutations that seriously alter the function of the ABCA7 gene.2 The mutations in genes other than ABCA7 make it difficult to determine pathogenicity. In this letter, we report a case of the R278I mutation in PSEN1, which has not been reported in Korean familial EOAD patients.